Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Inflammatory markers in dialysis: epidemiological data].

Ch Combe1, M C Cazin, B Vendrely

  • 1Service de néphrologie, Centre hospitalier universitaire de Bordeaux. christian.combe@chu-bordeaux.fr

Nephrologie
|December 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogen.

Transplant infectious disease : an official journal of the Transplantation Society·2012
Same author

Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4, south-western France, June 2011.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2011
Same author

Outbreak of haemolytic uraemic syndrome and bloody diarrhoea due to Escherichia coli O104:H4, south-west France, June 2011.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2011
Same author

Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts.

HIV medicine·2007
Same author

[Linezolid, the first oxazolidinone antibiotic].

Medecine et maladies infectieuses·2005
Same author

[Radiographic diagnosis in bone and joint infection management].

Medecine et maladies infectieuses·2004
Same journal

Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment.

Nephrologie·2004
Same journal

[Acute renal failure and 2,8-dihydroxyadeninuria].

Nephrologie·2004
Same journal

[Phototherapy and hemodialysis pruritus].

Nephrologie·2004
Same journal

[Pregnancy and hemodialysis].

Nephrologie·2004
Same journal

[Role of dietary fibers in the nutritional management of chronic renal failure].

Nephrologie·2004
Same journal

[Abstracts of the VI Meeting of the Society of Nephrology and of the Francophone Society of Dialysis. Marseille, France, 28 September-1 October 2004].

Nephrologie·2004
See all related articles

Dialysis patients show elevated inflammatory markers, linked to malnutrition and increased cardiovascular risks. This highlights the critical MIA syndrome, impacting patient health and survival.

Area of Science:

  • Biochemistry
  • Nephrology
  • Immunology

Context:

  • Dialysis patients exhibit significantly higher inflammatory marker levels (e.g., C-reactive protein) compared to the general population.
  • Chronic inflammation is a known risk factor for cardiovascular events in the general population.
  • The causes of chronic inflammation in dialysis patients are multifactorial, potentially involving the dialysis process itself.

Purpose:

  • To explore the elevated inflammatory markers in dialysis patients.
  • To investigate the association between inflammation, malnutrition, and cardiovascular disease in this population.
  • To define and understand the MIA syndrome.

Summary:

  • Elevated inflammatory markers are common in dialysis patients.
  • These markers correlate with malnutrition, increased cardiovascular morbidity, and mortality.

Related Experiment Videos

  • The interplay of inflammation, malnutrition, and atherosclerosis constitutes the MIA syndrome.
  • Impact:

    • Understanding the MIA syndrome is crucial for managing dialysis patients.
    • Identifying and addressing inflammation may reduce cardiovascular risks.
    • This research underscores the need for integrated approaches to patient care in nephrology.